Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Receivables (2016 - 2025)

GeoVax Labs' Receivables history spans 15 years, with the latest figure at $532771.0 for Q2 2025.

  • Quarterly results put Receivables at $532771.0 for Q2 2025, up 77.19% from a year ago — trailing twelve months through Jun 2025 was $532771.0 (up 77.19% YoY), and the annual figure for FY2024 was $659409.0, changed.
  • Receivables for Q2 2025 was $532771.0 at GeoVax Labs, down from $1.5 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.5 million in Q1 2025 to a low of $49006.0 in Q4 2021.
  • The 4-year median for Receivables is $532771.0 (2025), against an average of $526644.0.
  • The sharpest move saw Receivables plummeted 73.17% in 2021, then surged 77.19% in 2025.
  • Year by year, Receivables stood at $49006.0 in 2021, then surged by 103.09% to $99526.0 in 2022, then skyrocketed by 562.55% to $659409.0 in 2024, then decreased by 19.2% to $532771.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $532771.0, $1.5 million, and $659409.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.